Tuttle Capital Management LLC Buys 272 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Tuttle Capital Management LLC increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 34.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,055 shares of the company’s stock after buying an additional 272 shares during the quarter. Tuttle Capital Management LLC’s holdings in HCA Healthcare were worth $317,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare in the 2nd quarter valued at about $33,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $39,000. Canoe Financial LP bought a new stake in HCA Healthcare in the 3rd quarter valued at $41,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare during the third quarter worth $41,000. Finally, Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth about $44,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 1.7 %

Shares of HCA Healthcare stock opened at $307.97 on Tuesday. HCA Healthcare, Inc. has a 1 year low of $276.50 and a 1 year high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a market capitalization of $78.01 billion, a PE ratio of 13.83, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. The firm’s 50 day moving average is $320.56 and its 200 day moving average is $353.55.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were issued a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare’s payout ratio is presently 11.85%.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. Oppenheimer raised their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Truist Financial cut their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, TD Cowen cut their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.